Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition.
Misiachna A, Konecny J, Kolcheva M, Ladislav M, Prchal L, Netolicky J, Kortus S, Zahumenska P, Langore E, Novak M, Hemelikova K, Hermanova Z, Hrochova M, Pelikanova A, Odvarkova J, Pejchal J, Kassa J, Zdarova Karasova J, Korabecny J, Soukup O, Horak M.
Misiachna A, et al. Among authors: hermanova z.
Biomed Pharmacother. 2024 Sep;178:117201. doi: 10.1016/j.biopha.2024.117201. Epub 2024 Jul 24.
Biomed Pharmacother. 2024.
PMID: 39053419
Free article.